In high-grade glioma, deletion of SOX7 reduced CCL17, CCL22, and CCL5, which subsequently decreased Treg cells, while deletion of SOX17 increased CCL17 concentration and recruitment of Treg cells [154]. Here, CCL17 is linked to central nervous system cancer.